AstraZeneca COVID-19 Vaccine and Rare Blood Clots

The AstraZeneca COVID-19 vaccine was pulled off the market due to a decline in demand, not because of newly admitted risks. The vaccine had a known rare risk of dangerous blood clots, which were reported and acknowledged early on. Social media posts misleadingly linked the decision to the company's court documents, leading to misinformation about vaccine safety.